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Abstract
c-Secretase complexes (GSECs) are multimeric membrane
proteases involved in a variety of physiological processes and
linked to Alzheimer’s disease (AD). Presenilin (PSEN, catalytic
subunit), Nicastrin (NCT), Presenilin Enhancer 2 (PEN-2), and Ante-
rior Pharynx Defective 1 (APH1) are the essential subunits of
GSECs. Mutations in PSEN and the Amyloid Precursor Protein (APP)
cause early-onset AD. GSECs successively cut APP to generate
amyloid-b (Ab) peptides of various lengths. AD-causing mutations
destabilize GSEC-APP/Abn interactions and thus enhance the
production of longer Abs, which elicit neurotoxic events underlying
pathogenesis. Here, we investigated the molecular strategies that
anchor GSEC and APP/Abn during the sequential proteolysis. Our
studies reveal that a direct interaction between NCT ectodomain
and APPC99 influences the stability of GSEC-Abn assemblies and
thereby modulates Ab length. The data suggest a potential link
between single-nucleotide variants in NCSTN and AD risk. Further-
more, our work indicates that an extracellular interface between
the protease (NCT, PSEN) and the substrate (APP) represents the
target for compounds (GSMs) modulating Ab length. Our findings
may guide future rationale-based drug discovery efforts.
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Introduction
c-Secretase intramembrane proteases (GSECs) play multifaceted
roles in physiology and disease. Of great relevance is their critical
involvement in Alzheimer’s disease (AD) pathogenesis, where
altered cleavage of the Amyloid Precursor Protein (APP; Fig 1A),
and concomitant, relative increase in the generation of longer vs.
shorter amyloid-b (Ab) peptides, has been proposed to underlie the
disease (Selkoe & Hardy, 2016; Szaruga et al, 2017). GSEC activity
is exerted by a group of heteromultimeric, membrane-embedded
complexes composed of Presenilin (PSEN1 or PSEN2; Li et al,
2000), Nicastrin (NCT) (Yu et al, 2000), Presenilin Enhancer 2
(PEN-2; Francis et al, 2002), and Anterior Pharynx Defective 1
(APH1A or APH1B; Francis et al, 2002; Goutte et al, 2002) in a
1:1:1:1 stoichiometric ratio (Lazarov et al, 2006; Sato et al, 2007;
Bai et al, 2015b). PSEN bears the catalytic center of the enzyme (De
Strooper et al, 1998; Steiner et al, 1999; Wolfe et al, 1999; Ahn
et al, 2010), while the other “non-catalytic” subunits of the protease
are required for the complex assembly, activation, structural stabil-
ity/turnover, and trafficking (Thinakaran et al, 1996; Kim et al,
2003; Luo et al, 2003; Takasugi et al, 2003; Zhang et al, 2005). Once
the quartet has been assembled, PSEN undergoes auto-endoproteo-
lytic cleavage, which yields an active pentameric protease complex,
with the catalytic center located at the interface between the N- and
C-terminal fragments (NTF vs. CTF) of PSEN (De Strooper, 2003;
Edbauer et al, 2003; Selkoe & Wolfe, 2007).
In addition to the proteolytic processing of APP, the cleavage of
many other type I membrane proteins, such as Notch, ErbB4, and
N-Cadherin (reviewed in Haapasalo and Kovacs 2011), positions
GSEC activity as a regulator of several key physiological events
during embryonic development, hematopoiesis, and normal func-
tioning of the nervous and immune system, as well as of disease
processes, such as cancer (Jurisch-Yaksi et al, 2013; McCarthy et al,
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2017). Interestingly, the GSEC substrates are remarkably different in
their amino acid sequences and lack any obvious common struc-
tural features (Beel & Sanders, 2008; Lleo´, 2008). In fact, the only
known prerequisite for GSEC cleavage is the removal of protruding
ectodomains (when present) from type I membrane proteins by
protein sheddases (Struhl & Adachi, 2000; Kopan & Ilagan, 2004), a
step that generates C-terminal transmembrane domains (TMDs)
with short ectodomains—the immediate GSEC substrates—that may
only then undergo GSEC-mediated proteolysis.
APPC99 is the most studied substrate of GSECs due to its genetic
and biochemical link to AD pathogenesis. Extensive research has
revealed a rather unique mechanism by which APPC99, the C-terminal
fragment generated by b-secretase-mediated APP ectodomain shed-
ding, is sequentially cut by GSECs (Qi-Takahara, 2005; Yagishita et al,
2008; Takami et al, 2009). The first GSEC-mediated endopeptidase (e)
cleavage releases a soluble cytosolic fragment (APP intracellular
domain, AICD) and generates a transmembrane fragment (Ab48 or
Ab49), which is successively cut by carboxypeptidase-like (c) cleav-
ages, along the following product lines: Ab49 ? Ab46 ? Ab43 ?
Ab40 ? Ab37 or Ab48 ? Ab45 ? Ab42 ? Ab38 (Fig 1A). The
release of an Abn peptide into the luminal/extracellular environment
ends the sequential process (Takami et al, 2009). Importantly, the
position of the e-cleavage on APPC99 defines the type of Ab products
(product line), while the efficiency of the sequential c-cleavages
(number of cuts per substrate molecule, so-called GSEC processivity)
determines the length of the N-terminal Ab products.
Of note, mutations in both GSEC (enzyme, E) and APP (sub-
strate, S) lead to early-onset familial AD (FAD; Goate et al, 1991;
Sherrington et al, 1995). Importantly, disease-causing mutations in
PSEN1 and PSEN2 genes consistently impair the efficiency of the
c-cleavages, shifting Ab profiles toward the generation of longer
amyloidogenic peptides (Cha´vez-Gutie´rrez et al, 2012; Fernandez
et al, 2014; Moore et al, 2015; Veugelen et al, 2016). This so-
called “GSEC dysfunction” promotes—as demonstrated by the
analysis of post-mortem brain samples from FAD patients (Szaruga
et al, 2015)—the production of longer Ab≥42 peptides, which trig-
ger neurotoxic events underlying AD (Karran & De Strooper, 2016;
Selkoe & Hardy, 2016). Furthermore, many but not all FAD-
causing PSEN variants (Cha´vez-Gutie´rrez et al, 2012; Fernandez
et al, 2014; Szaruga et al, 2015) impair the initial GSEC
A
B
Figure 1. Schematic representation of APP processing and structural model (PDB: 5FN3) of the potential enzyme–substrate interface.
A In the amyloidogenic pathway, the ectodomain shedding of the full length APP (flAPP) by BACE yields the immediate GSEC substrate, APPC99. GSEC endopeptidase
cleavage of APPC99 generates APP intracellular domain (AICD50-99 or AICD49-99) and a “de novo” generated Ab substrate (Ab48 or Ab49, respectively). While the AICDs
are released, the Ab48 and Ab49 are subjected to subsequent GSEC proteolysis (carboxypeptidase-like c-cleavages).
B GSEC structure with co-purifying helical peptide (PDB: 5FN3) is presented. PSEN1 is shown in light brown, PEN-2 in dark brown, APH1A in gold, NCT in green, and the
co-purifying helical peptide in red. The topology of the helical peptide (putative GSEC substrate) is indicated by the amino and carboxyl terminal groups. The interface
between the N-terminal part of the helical peptide, the NCT ectodomain and PSEN1 is magnified, and NCT side chains are shown.
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endopeptidase (e-) cleavage and thus may have detrimental effects
on GSEC-mediated signaling cascades.
Importantly, our recent studies (Szaruga et al, 2017) have shown
that the relative stabilities of the GSEC-APP/Abn (E-S) complexes,
formed during the sequential cleavage of APPC99 by GSEC, control
the efficiency of the sequential proteolysis and thereby define the
length of Ab products. In addition, they have demonstrated that
pathogenic mutations in PSEN1 and in APP destabilize the GSEC-
APP/Abn interactions, leading to the “premature” release of longer,
more hydrophobic Abs (Szaruga et al, 2017). Of note, a remarkable
correlation between the magnitude of the mutant-induced weaken-
ing of the stability of the E-S complexes and the corresponding age
of disease onset (Szaruga et al, 2017) places the generation of longer
Ab≥42 peptides central to AD pathogenesis. The novel link between
the E-S complex (structural) stability and AD pathogenicity
prompted us to investigate the molecular mechanisms securing
GSEC-APP/Abn interactions. Here, we applied a structure-based
functional approach to determine the molecular strategies that
anchor APP/Abn during GSEC-mediated proteolysis. Our analyses
reveal that a direct interaction between the NCT ectodomain and
APPC99/Abn modulates the stability of GSEC-APP/Abn interactions
and therefore regulates Ab product length. In fact, the data raise the
intriguing possibility that AD-causing or protective single-nucleotide
variants (SNVs) may exist in the NCSTN gene. Furthermore, our
analysis implicates the extracellular interface formed between GSEC
(NCT, PSEN) and APPC99 in the regulation of the response to small
compounds, referred to as GSEC modulators (GSMs). Collectively,
these insights may guide future drug discovery efforts and the devel-
opment of innovative strategies targeting safely and efficiently the
destabilized GSEC-APP/Abn assemblies in AD.
Results
Structural data reveal a potential direct, short-distance
interaction between NCT and the substrate
We departed from the PDB:5FN3 high-resolution GSEC structure to
investigate the structural determinants securing E-S complexes and
thus controlling Ab length. We hypothesized that this structure of
GSEC (Fig 1B) (Bai et al, 2015a), which contains a co-purifying heli-
cal peptide (putative substrate), depicts the interaction between
GSEC and a “de novo” generated long Ab substrate, just before it
engages into the next catalytic turnover. In our working model, orig-
inally presented in Szaruga et al (2017) and discussed in-depth here,
key interactions between GSEC and the extracellular part of the
putative substrate play a critical role in the stabilization of the E-S
assemblies during the sequential proteolysis of Abn substrates.
Accordingly, we explored the presumed E-S co-structure to define
interactions that could contribute directly to the regulation of the
strength of the GSEC-APP/Ab interactions. Interestingly, we found
potential contact sites between the extracellular part of the helical
co-purifying peptide and the NCT ectodomain (amino acid (aa) resi-
dues 242–243 in human or 241–242 in mouse NCT (mNCT); please
note that residue numbering used in this report corresponds to the
sequence of mNCT unless specified otherwise; Fig 1B, zoom-in) as
well as with the first extracellular loop of PSEN1. While our recent
analysis of FAD-linked PSEN1 variants (Szaruga et al, 2017) has
demonstrated the participation of the first extracellular loop of
PSEN1 in the (de)stabilization of GSEC-APP/Ab interactions, the
involvement of the ectodomain of NCT in the strength of E-S inter-
actions has not been shown before and, if true, would provide novel
insights into the roles of the “non-catalytic” GSEC subunits in the
regulation of GSEC processivity of APP (Ab length). Therefore, we
investigated the contribution of NCT ectodomain to the stability of
GSEC-APP/Abn interactions, which defines enzyme processivity.
NCT ectodomain—aa 241-244—regulates GSEC processivity
of APPC99
To challenge the potential involvement of the NCT-241-242 region
in the regulation of the GSEC processivity of APPC99, we performed
Ala/Phe mutagenic scanning of the region of interest and of the two
neighboring amino acids on each side (NCT-F239A/F, NCT-S240A/
F, NCT-I241A/F, NCT-N242A/F, NCT-P243A/F and NCT-E244A/F),
followed by functional evaluation of the GSEC complexes in cell-
based assays. To this end, we used NCT knock-out (KO) mouse
embryonic fibroblasts (MEFs; Li et al, 2003) stably expressing either
wild-type or mutant NCT and transiently expressing wild-type
APPC99 substrate. Importantly, SDS–PAGE/Western blot analysis
showed that all mutants restored the assembly, maturation and
activity of GSEC, as indicated by the levels of mature NCT and PEN-
2 as well as the endoproteolytic generation of PSEN1-NTF and
PSEN1-CTF fragments (Fig EV1A). To determine the effects of the
tested mutant NCTs on GSEC processivity of APP, we quantified
secreted Ab38, Ab40 and Ab42 peptides by multi-spot enzyme-
linked immunosorbent assay (MSD-ELISA) and Ab43 by standard
ELISA. In line with our previous studies, Ab43 was produced at low
levels relative to the other (Ab38/Ab40/Ab42) peptides in wild-type
or mild destabilizing (such as FAD-linked V89L and R269H PSEN1)
conditions (Veugelen et al, 2016; Fig EV2). We, therefore, used the
Ab (38 + 40)/42 ratio (product/substrate ratio of the 4th GSEC cata-
lytic turnover) to estimate the overall processivity of GSEC toward
APP. Importantly, we included the FAD-linked PSEN1-L166P,
PSEN1-V89L and PSEN1-R269H mutant cell lines (Psen1//
Psen2/ MEFs (Nyabi et al, 2002) stably expressing respective
PSEN1 mutants) transiently expressing APPC99 as reference samples
in the analyses. The PSEN1 pathogenic variants were selected based
on their differential location in the PSEN1 structure and distinct clin-
ical ages of disease onsets (24, 48.6 and 55 years, respectively; Cruts
et al, 2012). In line with the reported detrimental effects of the FAD-
linked PSEN1 mutations on GSEC processivity of APP (Cha`vez-
Gutie`rrez et al, 2012; Fernandez et al, 2014; Veugelen et al, 2016),
all tested pathogenic mutant GSECs lowered the Ab (38 + 40)/42
ratio relative to the wild-type enzyme. The results thus validate the
use of the Ab (38 + 40)/42 ratio for the detection of changes in the
sequential GSEC-mediated cleavage of APP.
With regard to NCT, Ala/Phe substitutions of aa NCT-I241, NCT-
N242 and NCT-E244 significantly altered the Ab (38 + 40)/42 ratio,
supporting the involvement of NCT ectodomain in the regulation of
the sequential GSEC cleavage of APP (Fig 2A). Interestingly, substi-
tutions at these positions shifted enzyme processivity in both direc-
tions, with the NCT-I241A substitution, and to a lesser extent the
E244A and E244F mutants, enhancing the efficiency of the sequen-
tial GSEC cleavages on APP, and the NCT-N242F mutation hindering
the successive proteolysis. Notably, the NCT-N242F substitution
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reduced GSEC processivity of APP to the levels similar to those
exhibited by the FAD pathogenic PSEN1-V89L variant (Fig 2A).
Based on these data, we selected positions NCT-241, NCT-242
and NCT-244 for further analysis. In the second round of site-
directed mutagenesis, we replaced the hydrophobic isoleucine at the
position 241 with polar aa of small–medium size (Ser and Gln) or
with differentially charged side chains (Asp, Glu and Lys). As
shown in Fig 2B, all generated mutants reconstituted active GSEC
complexes. Our analysis revealed that the introduction of negatively
charged residues (Asp or Glu) resulted in a (mean  SD)
2.66  0.45 and 2.1  0.26 fold elevation in the Ab (38 + 40)/42
ratio, respectively (Fig 2C), while other tested mutations at this
position did not significantly alter this ratio. Furthermore, the dif-
ferential effects of the I241E vs. I241Q mutants on the Ab (38 + 40)/
42 ratio suggest that a charge–charge interaction underlies the acti-
vation of the sequential GSEC-mediated proteolysis observed for the
NCT I241E substitution. To test whether the introduction of a nega-
tive charge next to I241 would also increase GSEC processivity, we
mutated NCT-N242 to Asp or Glu. To investigate further the role of
position N242 on GSEC processivity of APP, we introduced bulky
residues with polar (Tyr, Trp) or charged (Lys) side chains at this
position, generated mutant cell lines, and tested them in cell-based
GSEC activity assays. The analysis showed that all mutants at posi-
tion 242 rescue GSEC complex formation (Fig 2B) and that introduc-
tion of a bulky aromatic group at position NCT-242 is detrimental
for GSEC processivity (Fig 2C). Furthermore, it revealed that the
NCT-N242E/D mutations, in contrast to Asp/Glu residues at posi-
tion 241, result in mild increments in the Ab (38 + 40)/42 ratio,
indicating that a charge–charge interaction with activating effects on
GSEC processivity of APP is optimally established with negatively
charged NCT residues at position 241. Of note, mutagenesis of the
E244 residue did not reveal any additional substitutions affecting
GSEC processivity in a significant manner. In conclusion, the data
demonstrate that residues 241, 242, and to a lesser extent 244, in
NCT ectodomain contribute to the mechanism(s) governing the effi-
ciency of the successive GSEC-mediated cleavage on APP and thus
modulate the length of Ab product peptides.
Residues 241-242 in NCT ectodomain regulate the stability of
GSEC-APP/Ab interactions
We then investigated whether the observed effects of mutations at
positions NCT-I241 and NCT-N242 on GSEC processivity of APP are
mediated by changes in the stability of GSEC-APP/Ab complexes.
To this end, we evaluated temperature-mediated destabilization of
GSEC-APP/Ab interactions in wild-type and mutant NCT MEF cell
lines, transiently expressing APPC99 substrate, cultured at 42°C.
Importantly, we first determined that prolonged incubation at 42°C
does not affect cell viability of wild-type MEFs (Fig 3A) and that the
Ab (38 + 40)/42 ratio was sensitive to detect temperature-induced
changes in the stability of wild-type and FAD-linked PSEN1 L166P,
V89L and R269H GSEC-APP/Ab assemblies. Clearly, the elevated
temperature significantly affected the efficiency of the 4th APP cleav-
age mediated by the wild-type enzyme, as demonstrated by the Ab
(38 + 40)/42 ratio (95% CI: 78–86% relative to 37°C, indicated with
a blue box), and further enhanced the proven E-S destabilizing
effects (Szaruga et al, 2017) of the FAD-linked PSEN1 mutants
(Fig 2C vs. 3B, Ab (38 + 40)/42 ratio (mean  SD) = 9.2  1.3%,
59.9  4.9%, and 80.8  6.8% at 37°C vs. 7.3  0.66%,
41.9  6.1%, and 70.4  4.9% at 42°C for PSEN1 L166P, V89L and
R269H mutants, respectively). These data validate the use of the
cell-based GSEC thermoactivity assay to assess the (de)stabilizing
nature of structural variants in the GSEC complex on the APPC99
sequential proteolysis. Thus, we employed this assay to evaluate the
potential stabilizing or destabilizing effects of mutant NCT-I241E,
NCT-N242E or NCT-N242Y on E-S interactions. The cell-based ther-
moactivity assay revealed that the NCT-I241E and NCT-N242E
mutants counteract the detrimental effect of temperature on the Ab
(38 + 40)/42 ratio, indicating that their effects on GSEC processivity
are mediated by the stabilization of GSEC-APP/Ab interactions
(Fig 3B). On the contrary, the NCT-N242Y substitution, similar to
FAD-linked PSEN1 mutations, enhanced the detrimental effect of
temperature on Ab (38 + 40)/42 ratio. These results demonstrate
that the aa residues 241–242 within the NCT ectodomain influence
Ab generation by modulating the strength of GSEC-APP/Ab interac-
tions.
NCT residue 241 establishes a direct, short-distance interaction
with the APP/Ab substrate
To gain insights into the structural basis underlying the (de)stabiliz-
ing effects of NCT ectodomain on GSEC-APP/Ab interactions, we
performed molecular dynamics (MD) simulations with the APP-
derived Ab49 substrate bound to human GSEC as the co-purifying
peptide in the PDB:5FN3 structure (Fig 4A and I). Interestingly, the
simulations suggested that human hNCT-I242 (I241 in mNCT) and
APPC99-K28 are in close proximity to each other (mean Ca-Ca
distances of approx. 10 A˚ during the 3 ls sampling time). A nega-
tively charged residue present at position hNCT-242 induced the
formation of a salt bridge between hNCT-I242E (GSEC) and APPC99-
K28 in 34% of all sampled frames, while in 24% of all observations,
the two side chains were bridged by a water molecule (Fig 4A, II
and III). Subsequently performed post-processing free energy
calculations using molecular mechanics Poisson–Boltzmann surface
area (MMPBSA) method (Genheden & Ryde, 2015) indicated
that hNCT-E242 indeed stabilizes GSEC-APP/Ab interactions by
2.90  0.13 kcal/mol (mean  SEM, with N = 1,500). Further-
more, the simulations supported the importance of the interactions
between APP ectodomain and the first extracellular loop of PSEN1
(residues 109–118), a region reported previously to be involved in
the substrate recognition (Takagi-Niidome et al, 2015) and mutated
in FAD.
Based on the theoretical analysis, we speculated that the forma-
tion of a salt bridge between positions 241 in mouse NCT and K28
in APPC99 could explain the increments in the GSEC processivity of
APP observed for the NCT-I241E/D mutants (Figs 2C and 4B, I vs.
II). To challenge this possibility experimentally, we “inverted” the
putative salt bridge between NCT-I241 and APPC99-K28. If our
hypothesis were correct, the “inverted” salt bridge (NCT-I241K and
NCT-K28E) would also enhance GSEC processivity. Of note, previ-
ous studies have shown that K28 in APPC99/Ab critically regulates
Ab length by an unknown mechanism (Ren et al, 2007; Kukar et al,
2011; Ousson et al, 2013; Jung et al, 2014). Accordingly, the single
K28E APPC99 mutation shifted Ab profiles (generated by the wild-
type GSEC) toward the generation of shorter Ab peptides, relative to
the wild-type substrate (Fig 4B, I vs. III). Yet, the inclusion of the
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“inverted” salt bridge (I241K–K28E) further enhanced GSEC proces-
sivity of APPC99 (Fig 4B, III vs. IV), supporting a stabilizing role of
the ionic interaction between NCT and APP/Ab substrates.
ELISA analysis of Ab profiles revealed a strong enhancement of
the GSEC-mediated generation of Ab37 and Ab38, at the expense of
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mutant APPC99-K28E substrates. Therefore, we included the contri-
bution of the Ab37 peptide in the estimation of GSEC processivity of
APP by calculating the ((Ab 37/40) + (Ab 38/42)) ratio. The results
clearly showed that the GSEC processivity of the mutant APPC99-
K28E was further enhanced when a positive charge was introduced
at the position NCT-241 (I241K) (Fig 4C, NCT-WT–APPC99-K28E vs.
NCT-I241K–APPC99-K28E). This additive effect provides experimen-
tal evidence in support of a site-specific interaction between NCT-
I241 and APPC99-K28, with functional consequences on the effi-
ciency of the sequential GSEC proteolysis.
To further verify the interaction between the aa at the positions
241 in NCT and 28 in APPC99, we performed chemical cross-linking
experiments using the heterobifunctional cross-linker N-b-maleimi-
dopropyl-oxysuccinimide ester (BMPS) that presents amine- and
thiol-reactive groups connected by a 5.9 A˚ spacer arm (Fig 5A). To
this end, we generated mutant NCT-I241C and stably expressed it in
the Ncstn/ MEFs. SDS–PAGE/Western blot analysis of the GSEC
complexes in the generated cell line showed the presence of the
mature, fully glycosylated NCT as well as PEN-2 and an efficient
endoproteolytic generation of PSEN1-NTF and PSEN1-CTF, relative
◀ Figure 2. NCT ectodomain regulates GSEC processivity toward APPC99.A Ala/Phe substitutions of aa 239-244 were introduced in the NCT ectodomain to evaluate the role of this region in the regulation of GSEC processivity. Ab38, Ab40 and
Ab42 levels present in the conditioned medium collected from KO NCT MEF cells rescued with WT or respective mutant NCT GSECs and transiently expressing with
APPC99 were quantified by ELISA. Ab(38 + 40)/42 ratio was calculated to determine GSEC processivity toward APPC99. DKO PSEN1/PSEN2 MEFs rescued with the
indicated FAD PSEN1 mutant and transduced with APPC99 were used as references.
B Representative SDS–PAGE/Western blot analysis of CHAPSO-solubilized membranes from KO NCT MEF cell lines stably expressing WT or mutant NCT subunits. The
presence of mature, glycosylated NCT, N-terminal and C-terminal fragments of the endoproteolyzed PSEN1 and PEN-2 (compared to NCT knock-out (KO) cells)
indicates that WT and mutated NCTs reconstitute GSEC complexes. Arrowheads indicate the position of molecular weight markers.
C Quantification of the effects of the indicated substitutions of aa 241, 242 and 244 in NCT on GSEC processivity of APPC99, estimated as indicated above by the Ab
(38 + 40)/42 ratio. Fig EV1B shows the corresponding Ab42/40 ratios.
Data information: Data are presented as mean  SD, N ≥ 4 independent experiments. One-way ANOVA followed by Dunnett’s post hoc test in comparison with WT was
used to determine statistical significance of all tested NCT mutants; *P > 0.05, **P > 0.01, ***P > 0.001, ****P > 0.0001, F(DFn, DFd): F(27, 230) = 84,22.
Source data are available online for this figure.
A B
Figure 3. The NCT ectodomain contributes to the stability of GSEC-APP/Abn complexes and accordingly modulates Ab product length.
A (Top) Representative bright-field microscopy images show MEF cells stably expressing WT or NCT mutant GSECs after 24-h incubation at 37°C and 42°C. 25 lm scale
bar is shown. (Bottom) Cell viability determined at the indicated time points is not affected by prolonged (≥ 24 h) incubation at 42°C. Data are presented as
mean  SD of 4 replicates.
B Relative GSEC-APP/Abn stabilities were assessed in cell-based GSEC thermoactivity assays, which evaluate changes in GSEC processivity (Ab(38 + 40)/42 ratio) upon
incubation at 42°C for 24 h, relative to 37°C. Ab peptides in the conditioned medium collected from the indicated MEF cell lines (transiently expressing APPC99) were
quantified and the Ab(38 + 40)/42 ratios determined. The data are shown as mean  95% CI, as % of the WT GSEC cell line incubated at 37°C for 24 h, N = 6
independent experiments. One-way ANOVA followed by Dunnett’s post hoc test in comparison with WT was used to determine the statistical significance (F(DFn,
DFd): F(6, 46) = 100); ****P > 0.0001 compared to WT at 37°C, and #P > 0.05, ##P > 0.01 and ####P > 0.0001 compared to WT at 42°C. Note: Ab profiles (including
Ab43 levels) normalized to total Ab quantified in the cell-based thermoactivity assays with the different mNCT WT/mutants are shown in Fig EV2.
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to the wild-type condition (Fig EV3A), indicating that the mutant
NCT-I241C rescues GSEC complex formation and activity. Next, we
expressed transiently the wild-type APPC99 substrate in the wild-type
and the NCT-I241C cell lines. In addition, we included non-trans-
duced cell lines as controls. To enhance the formation of the E-S
complexes and prevent their dissociation due to proteolysis, we
treated the cells overnight with 1 lM GSEC inhibitor X, a transition
state analog that halts substrate turnover but allows substrate bind-
ing to GSEC (Shearman et al, 2000). Then, we harvested the cells,
prepared total membrane fractions, and subjected these fractions to
a 2-step cross-linking protocol using BMPS. To evaluate the cross-
linking products, we detergent-extracted membrane proteins and
performed SDS–PAGE/Western blot analyses using 82E1
anti-APPC99 (binds to the N-terminus of APPC99/Ab) and anti-NCT
antibodies (Fig 5B). Immunoblotting with the anti-APPC99 antibody
confirmed the expression of the substrate in the transduced cells
(Fig 5B, lanes 3 and 4, bottom panel) and revealed the presence of a
higher molecular weight band (~100 kDa) exclusively in the cross-
linked extracts prepared from the NCT-I241C cell line overexpress-
ing the APPC99 substrate (Fig 5B, lane 4 vs. 3, top panel). Further
analysis with an anti-NCT antibody showed that the electrophoretic
mobility of the “high molecular weight” APPC99/Ab-positive band
(cross-linked NCT-APPC99/Ab complex) is slightly shifted toward a
higher molecular mass, relative to the mobility of the mature, glyco-
sylated NCT (Figs 5C and EV3C). The observed shift supports the
cross-linking of the wild-type APP/Ab substrate and mature mutant
NCT-I241C and furthermore indicates that the Cys241 in NCT is at
least within 5.9 A˚ distance from a free amine group on the substrate,
likely K28 in APPC99.
Based on the apparent short distance between NCT and APPC99,
and to confirm the involvement of K28 in the direct interaction with
NCT-241, we tested the potential formation of a disulfide bond
between these positions (Fig 5D). To this end, we expressed the
APPC99-K28C substrate in the NCT-I241C cell line, prepared total
membranes, and analyzed SDS-extracted membrane proteins in
SDS–PAGE/Western blot with anti-APPC99/Ab and anti-NCT anti-
bodies under reducing and non-reducing conditions (Figs 5E and
EV3D). The presence of a high molecular weight APPC99/Ab-positive
band (~100 kDa) under non-reducing conditions demonstrated the
spontaneous formation of a disulfide bond between the NCT-I241C
and APPC99-K28C mutants (Fig 5E and F). Quantification of the inte-
grated densities of the high molecular weight band corresponding to
the NCT-APPC99/Ab on the anti-Ab immunoblot revealed that ~15%
(mean  SD: 15.4  5.7%, N = 3) of the substrate got cross-linked
to NCT (Fig EV3B). In conclusion, our analyses demonstrate that
the direct, short-distance interaction between NCT-241 and APPC99-
28 modulates Ab product profiles by stabilizing GSEC-APP/Ab inter-
actions.
NCT ectodomain (residue 242) mediates the response to
imidazole-based GSEC modulators
Previous studies highlight K28 in APPC99 as a critical determinant of
GSEC processivity of APP (Ren et al, 2007; Page et al, 2010; Kukar
et al, 2011; Ousson et al, 2013; Jung et al, 2014) and show that, in
addition to their effects on Ab length, mutations at this position alter
the response to GSMs (Page et al, 2010; Ousson et al, 2013; Jung
et al, 2014), but the underlying mechanisms remain unknown.
These intriguing findings and the short-distance interaction between
positions 28 in APPC99 and 241 in NCT prompted us to test the
response of mutant (de)stabilizing NCT GSEC complexes to GSMs
belonging to different classes (acidic vs imidazole-based, Fig 6A).
For this purpose, we transduced wild-type and mutant (NCT-I241E,
NCT-N242Y and NCT-N242F) MEF cell lines with wild-type APPC99,
as described before, and treated the cell cultures with 0.3 lM, 1 lM
GSM or vehicle control (0.1% DMSO) overnight. To evaluate the
response of wild-type and mutant GSEC complexes toward GSMs,
we collected the cell media and quantified Ab37, Ab38, Ab40 and
Ab42 levels by ELISA and determined Ab profiles (Figs 6B and
EV4A) as well as the Ab37/Ab40 and Ab38/Ab42 ratios (Fig EV4B
and C). The results revealed that the acidic GSM activates exclu-
sively the Ab42 ? Ab38 cleavage (Fig 6C, P-values for WT in
columns 1 and 4), while the imidazole-based GSMs II and III
strongly activate both GSEC product lines, which is in agreement
with previous findings (Page et al, 2010; Ousson et al, 2013). The
GSMs II and III thus shifted Ab profiles toward the production of the
Ab37 and Ab38 peptides (blue and orange bars in Fig 6B, respec-
tively), with concomitant reduction in the Ab40 and Ab42 species
(green and purple bars in Fig 6B, respectively).
Our analysis revealed that wild-type as well as mutant GSEC
complexes responded markedly to GSM I treatment (right upper
panel in Fig 6B), with the exception of the NCT-N242Y GSEC
mutant which showed a partial response (Figs 6C and EV4, P-values
for N242Y in column 4). Most importantly, we observed that the
NCT-N242Y and NCT-N242F mutant GSECs did not respond to GSM
II, as indicated by the Ab profiles (Fig 6B) showing that Ab40 (green
bar) remains the major Ab peptide produced by these mutant cell
lines in the presence of 1 lM GSM II. In fact, statistical analysis on
the Ab37/Ab40 and Ab38/Ab42 ratios reveals no significant dif-
ferences between the processivities of the NCT-N242Y and NCT-
N242F mutant cell lines treated with vehicle (DMSO) or 1 lM GSM
II (Fig 6C, P-values for N242F and N242Y in columns 2 and 5). In
◀ Figure 4. Direct, short-distance interaction between positions hNCT-242 and APP/Ab-28 regulates GSEC processivity toward APPC99.A Molecular dynamics simulations superimposing the cryo-EM-determined GSEC structure (PDB: 5FN3) with an NMR Ab structure (PDB: 1IYT) on the co-purifying
helical peptide (I) present hNCT-I242 and APPC99-K28 at the NCT ectodomain–APP interface, and modeling of the NCT I242E mutant suggests a direct (II) or indirect
(bridged by H2O, III) interaction between the NCT -E242 and the APPC99 -K28 side chains.
B Ab profiles (% contribution of individual Ab37, Ab38, Ab40 and Ab42 peptides to the total Ab levels (Ab37 + 38 + 40 + 42)) in the conditioned medium collected from
WT or mutant (NCT) MEF cells lines co-expressing WT or mutant APPC99 substrates were assayed by ELISA. Schematic models of the tested GSEC-APP complexes are
shown.
C To account for the increased production of Ab37 and Ab38 at the expense of Ab40 and Ab42 in the tested conditions, the ratio of ((Ab 37/40) + (Ab 38/42))/2 was
determined and used to estimate GSEC processivity of APPC99. All the data are presented as mean  SD, N ≥ 3; unpaired, two-tailed Student’s t-test was used to
determine the statistical significance. **P > 0.01 and ****P > 0.0001. Calculated T- and Df values were as follows: T = 11,63, Df = 16 (I241-K28 vs I241E-K28);
T = 11,37, Df = 14 (I241-K28 vs. I241-K28E); T = 4,572, Df = 8 (I241E-K28 vs I241-K28E); T = 4,497, Df = 5 (I241-K28E vs. I241K-K28E); and T = 2,561, Df = 7.
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contrast, the NCT-N242A GSEC mutant responded similarly to WT
toward GSM II (Fig 6B and C, P-values for N242A in columns 2 and
5). All together, these data demonstrate that bulky residues at the
NCT-242 position not only impair the stability of GSEC-APP/Ab
assembly (and therefore enzyme processivity, as shown in Fig 2C)
but also have an impact on the activation of GSEC by the imidazole-
based GSM II. These results could be explained by the contribution
of residue NCT-242 to the binding pocket of GSM II or to its partici-
pation in the allosteric mechanisms triggered upon GSEC-GSM inter-
action. We then reasoned that analysis of the mutant responses to
another imidazole-based compound could enable to distinguish
between these two scenarios. Interestingly, we found that the NCT-
N242Y and NCT-N242F mutant GSECs did respond to GSM III, as
indicated by the relative increments in Ab37 (blue bars) in the right
lower panel of Fig 6B and the significant changes in the Ab 37/40
and Ab 38/42 ratios for DMSO- vs. 1 lM GSM III-treated mutant cell
lines (Fig 6C, P-values for N242F and N242Y in columns 3 and 6).
These findings thus demonstrate that the mechanisms underlying
GSEC processivity of APP remain intact in the mutant NCT-N242F
and NCT-N242Y protease complexes, and point toward an altered
binding of imidazole-based GSM II to NCT-N242Y and NCT-N242F
GSECs. Furthermore, our studies also reveal a reduced response of
the NCT-N242Y, NCT-N242F and NCT-N242A mutant GSEC
complexes to GSM III in the presence of 0.3 lM GSM III compared
to the wild-type protease (Fig EV4). In conclusion, the differential
responses of GSEC complexes bearing NCT-N242A, NCT-N242Y and
NCT-N242F mutants toward imidazole-based GSM II and III (Fig 6B
and C) suggest partially distinct binding sites for these compounds.
Our studies therefore assign a direct and active role to the ectodo-
main of NCT in the GSEC modulation by GSMs.
Discussion
We have recently demonstrated that the stability of GSEC-APP/Abn
substrate interactions controls the length of Ab product peptides
and thereby affects the risk for AD. Notably, our previous findings
show that FAD-causing mutations destabilize GSEC-APP/Ab (E-S)
complexes and the magnitudes of their detrimental effects
remarkably correlate with age of disease onset (Szaruga et al,
2017). The novel pathogenic link motivated us to investigate the
intermolecular interactions that secure GSEC-Abn assemblies during
the sequential GSEC-mediated proteolysis. We departed from the
high-resolution structure of GSEC in complex with a co-purifying
helical peptide (PDB:5FN3, Bai et al 2015a). We hypothesize that
this structure depicts the interaction between GSEC and the frag-
ment generated after the initial proteolytic cleavage of the trans-
membrane domain of the substrate (de novo generated long Ab from
APPC99), just before it engages into the next catalytic turnover. The
putative substrate occupies the substrate binding site, but in
contrast to APPC83 (Zhou et al, 2019), only the most N-terminal part
of its transmembrane domain remains in a helical structure, while
its unstructured C-terminal part extends along the substrate binding
channel to reach the active site. We actually proposed that the first
endopeptidase-mediated backbone break exerts a strong destabiliz-
ing effect on the helical structure of APPC99, leading to this configu-
ration. In our model, further unwinding of the N-terminal helix of
the substrate must occur upon each GSEC cut, in order to provide
the length of the substrate to fill the S10–S30 enzyme pockets (Bolduc
et al, 2016b) during the stepwise catalysis. The sequential unwind-
ing of the N-terminal helix progressively destabilizes the E-S assem-
bly, increasing the probability of its dissociation and consequent
release of Abn. This “unwinding model”—originally proposed in
Szaruga et al (2017)—suggests that the interactions established
between the N-terminal helical structure of the substrate and the
protease “anchor” the E-S complex and thereby define the length of
the N-terminal products (Ab from APP). Interestingly, our analysis
identified a potential contact site between the ectodomains of NCT
(aa residues 241–242 in mNCT) and the co-purifying peptide (puta-
tive substrate). Accordingly, we hypothesized that the potential
“NCT-APP/Ab” interface could directly contribute to the stability of
E-S interactions and thereby modulate the length of Ab products.
Note that the established role of the non-catalytic subunits (NCT,
PEN-2 and APH1) of the protease in PSEN/GSEC function and turn-
over (Gertsik et al, 2015; Carroll & Li, 2016) supports their contribu-
tion to the stability of GSEC-APP/Ab complexes.
Our studies revealed differential contributions of residues 241–
242 in NCT to GSEC-Abn interactions, implicating for the first time
◀ Figure 5. Short-distance interaction between NCT 241 and APPC99 K28.A Chemical structure of the BMPS hetero-bifunctional (amine- and thiol-reactive groups) cross-linker.
B Introduction of Cys at position 241 in NCT allows chemical cross-linking of NCT and APPC99 with BMPS. Representative SDS–PAGE/Western blot shows cross-linked
NCT-APPC99, NCT and APPC99 bands in detergent-extracted membrane proteins from BMPS cross-linker-treated membranes prepared from MEF cell lines expressing
the indicated WT or mutant NCT GSEC complexes together with APPC99 or in the absence of the substrate. Orange, black and white arrows indicate the NCT-APPC99/
Ab cross-linked, mature NCT and immature NCT bands, respectively. Arrowheads indicate the position of molecular weight markers.
C Analysis of the Western blot density profiles in panel (B) shows that co-migration of NCT (orange arrow) with APPC99 shifts the cross-linked band toward a higher
molecular weight than the observed for mature NCT (black arrow). Immature NCT is indicated with an open (white) arrow. Full-range molecular weight density
profiles are shown in Fig EV3C.
D Schematic representation of the GSEC-APPC99 complex modified at NCT-I241 and APP-K28 by the introduction of Cys substitutions.
E Representative SDS–PAGE/Western blot presents NCT-APPC99, NCT and APPC99 expression in detergent-extracted membranes prepared from MEF cell lines co-
expressing the mutant NCT-I241C GSEC complex with the APPC99-K28C substrate. As negative control, the same sample was supplemented with b-mercaptoethanol
(BME) to reduce all disulfide bridges. A full-range molecular weight Western blot is shown in Fig EV3B. Orange, black and white arrows indicate the NCT-APPC99/Ab
cross-linked, mature NCT and immature NCT bands, respectively. Arrowheads indicate the position of molecular weight markers.
F Analysis of the integrated density profiles of the respective Western blot bands supports the spontaneous formation of a disulfide bond between NCT-I241C and
APPC99 K28C (mature NCT and immature NCT are indicated with black and white arrows, respectively). The filled orange arrow points at the high molecular weight
APPC99/Ab density (cross-linked NCT-APPC99/Ab band). Note that peak amplitudes for the cross-linked NCT-APPC99 and the mature NCT band were normalized to
similar values for clarity purposes. Full-range molecular weight density profiles are shown in Fig EV3D.
Source data are available online for this figure.
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C
Figure 6. GSECs destabilized by the N242F and N242Y NCT mutations do not respond to imidazole-based GSEC modulators.
A Chemical structures of acidic GSEC modulator (GSM I) and imidazole-based GSM II and GSM III (GSM B in Szaruga et al 2017).
B Ab profiles (% contribution of individual Ab37, Ab38, Ab40 and Ab42 peptides to the total Ab levels (Ab37 + 38 + 40 + 42)) in the conditioned medium collected from
vehicle (DMSO) or GSM-treated (1 lM final concentration) MEF cells co-expressing respective WT or mutant NCT GSEC with APPC99 were determined by ELISA. Data
generated using 0.3 lM GSM-treated MEF cells are shown in Fig EV4. Data are presented as mean  SD, N ≥ 3 independent experiments.
C Ab 37/40 and Ab 38/42 ratios were calculated to evaluate the efficiency of the GSEC-mediated cleavage of APPC99 (Fig EV4) and statistical analysis (P-values) (two-
way ANOVA with Sidak’s post hoc test) for the effect of GSMs on WT and mutant complexes is presented (response to GSM normalized to the corresponding vehicle
condition).
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the ectodomain of NCT in the mechanisms controlling Ab length.
Interestingly, we showed that aromatic substitutions at the position
NCT-242 (N242F/W/Y) significantly reduce GSEC processivity of
APP to the levels similar to those exhibited by FAD pathogenic
PSEN1 variants (Figs 2C and EV1B), while the presence of nega-
tively charged residues at the position NCT-241 promotes the
production of shorter Ab peptides. Further, cell-based GSEC ther-
moactivity analysis demonstrated that the mutant NCT induced
shifts in Ab profiles by influencing the stability of GSEC-APP/Abn
interactions (Fig 7).
The theoretical GSEC-Ab model (developed here) pointed toward
the existence of a positively charged residue in the APP substrate
and suggested a direct interaction between positions I242 in hNCT
and K28 in APPC99, which was confirmed in cross-linking experi-
ments. Of remark, the spontaneous formation of a disulfide bond
between NCT and APP (when Cys residues were introduced at posi-
tions 241 in mNCT and 28 in APPC99) defined it as a short-distance
interaction surrounded by an aqueous environment, and thus likely
located in the extracellular/luminal environment (Rehder & Borges,
2010).
During the preparation of this report, the co-structures of the
GSEC with the Notch or APPC83 substrate became available (Yang
et al, 2018; Zhou et al, 2019). Interestingly, the GSEC–Notch
complex shows an extracellular interface between the ectodomains
of the NCT subunit and Notch, with the NCT-241–242 aa located at
the E-S interface (Fig EV5A). The GSEC-APPC83 complex shows the
APP-K12 residue (corresponding to K28 in APPC99) in the proximity
to the NCT-241 residue; however, since the interface in the GSEC-
APPC83 structure is not fully resolved, it is possible that the cross-
linking of GSEC (PSEN1-Q112C) to the APPC83 V8C substrate affected
this region in the atomic model (Fig EV5B). The functional data
presented here, together with the novel GSEC–substrate co-struc-
tures (Yang et al, 2018; Zhou et al, 2019), suggest a conserved mech-
anism for the stabilization of GSEC–substrate interactions and may
support the involvement of NCT ectodomain in the substrate recog-
nition by the GSEC complex, by stabilizing the initial GSEC–substrate
assembly. Of note, the ectodomain of NCT was initially proposed to
act as a substrate receptor in the protease, with the anionic NCT-
E322 residue and the free N-terminal amine group of the substrate
interacting (Shah et al, 2005). However, the model has been chal-
lenged by biochemical studies (Cha´vez-Gutie´rrez et al, 2008; Zhao
et al, 2010) and the recent E-S structural data finally disproved it.
The currently accepted model for NCT function assigns to its ectodo-
main a rather passive role in the “substrate selection”, in which it
restricts—by steric hindrance—the access of substrates presenting
large ectodomains (Bolduc et al, 2016a). Our data provide compel-
ling evidence for additional, novel implications of the NCT ectodo-
main, i.e., its active role in the regulation of the GSEC processivity of
APP and the modulation of the response to GSEC modulators
(GSMs). Previous reports have shown that APP-K28 mutations exert
profound effects on Ab generation via an unknown mechanism (Ren
et al, 2007; Kukar et al, 2011) and alter the response to GSMs (Page
et al, 2010; Ousson et al, 2013; Jung et al, 2014). Here, we demon-
strate that the effects of K28 on APP processing are explained in part
by its interaction with the ectodomain of NCT.
The proven direct, short-distance interaction between K28 in
APPC99 and position 241 in NCT ectodomain (Fig 5) and their
shared implication in the regulation of GSEC processivity motivated
us to investigate the effects of the (de)stabilizing mutations at posi-
tions NCT-241/242 on the GSEC response to GSMs. Remarkably,
our data revealed that the substitutions in NCT-242 that destabilize
GSEC-APP/Ab interactions (N242F and N242Y, as demonstrated in
Fig 3) also had strong deleterious effects on the response to imida-
zole-based GSM II in both production pathways (> 90% reduction
for the mutant NCT-N242F and NCT-N242Y cell lines at 1 lM GSM
II relative to the wild-type GSEC, Fig EV4). Clearly, GSM II
promoted the conversion of Ab40 into Ab37 and Ab42 into Ab38 by
the wild-type protease but failed to engage the NCT-N242F/Y
mutant GSEC complexes on these specific cuts. The similar
responses of the wild-type and NCT-N242A mutant GSECs indicate
that bulky substitutions at position NCT-242 not only destabilize
GSEC-APP/Ab interactions, and accordingly change Ab product pro-
files, but also impair drastically the response to GSM II. The results
could be explained by the contribution of residue NCT-242 to the
formation of the binding pocket for GSM II or by its participation in
the allosteric mechanisms triggered upon GSEC-GSM interaction. In
this regard, our studies revealed that the NCT-N242F/Y mutant
GSEC complexes largely respond to GSM III. These observations
support the contribution of NCT to the formation of the binding
pocket for imidazole-based GSMs, rather than its participation in the
mechanisms underlying the response. Of note, the binding site of
another imidazole-based GSM (ST2038, structurally similar to the
GSM II) has been located to the first extracellular loop of PSEN-NTF
(Takeo et al, 2014), which according to structural data is in proxim-
ity to the identified NCT-APP interface. Furthermore, the novel
GSEC-Notch/APPC83 co-structures place the substrate in between
the studied NCT region and the first extracellular loop of PSEN1
(Fig EV5) supporting our conclusions. Finally, a cross-competition
study between the imidazole-based GSM (ST2038) and the acidic
GSM I shows that pre-treatment with GSM I substantially decreases
the affinity labeling of the GSEC complex by the ST2038 GSM
(Takeo et al, 2014), suggesting partially overlapping binding pock-
ets for acidic and imidazole-based GSMs. The lack of response of
the mutant NCT-N242Y to GSM I observed here supports a similar
conclusion.
Of potential clinical significance, the marked impact of the aa
substitutions within NCT ectodomain on APP processing suggests
the potential existence of AD-causing or protective single-nucleotide
variants (SNVs) in the NCSTN (i.e., NCT encoding) gene. The data
specifically highlight the position 242 in NCT, where a single-
nucleotide change—N242Y substitution—lowers GSEC processivity
to the levels associated with pathogenic PSEN1 mutations. Intrigu-
ingly, no AD pathogenic or protective mutations have been identi-
fied so far in NCT or in any of the non-catalytic subunits of the
GSEC complex. It should be noted that in clinical practice, genetic
testing varies between different centers and generally involves test-
ing specifically for known genetic causes of dementia syndromes
(Koriath et al, 2018). However, a high proportion of the genetic risk
for AD remains uncharacterized. Rare highly penetrant mutations in
PSEN1, PSEN2 and APP are thought to account for only 5-10% of
all early-onset AD (EOAD, onset < 65 y) cases, while the heritability
of EOAD has been estimated to range from 92 to 100%, thus leaving
90–95% of the affected families with an unidentified genetic cause
for the disease (Cacace et al, 2016). In late-onset AD, which has a
heritability of 70–80%, five new genetic risk loci have recently been
identified, with pathway analysis implicating immunity, lipid
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metabolism, tau binding proteins and APP metabolism (Kunkle
et al, 2019). Furthermore, the enrichment of rare variants in the
APP metabolism in this study suggests that additional rare variants
remain to be identified.
Collectively, the presented data demonstrate for the first time the
existence of an extracellular NCT-APP interface implicated in the
modulation of the strength of GSEC-APP/Ab interactions (and thus
Ab length) as well as in the response of E-S complexes to GSMs (E-S
stabilizers). Based on our original findings, the novel E-S structural
data (Yang et al, 2018; Zhou et al, 2019) and the literature, we
propose that the extracellular GSEC (NCT-PSEN)-APP interface
encompassing the aa region 241-242 in NCT ectodomain, K28 in
APP and the first extracellular loop of PSEN plays a critical role
in the stabilization of GSEC-APP/Abn interactions and is involved in
the binding of selected imidazole-based GSMs. Notably, the idea of
selectively targeting APP processing with substrate targeting
compounds (Kukar et al, 2008) has been raised in the past but has
been abandoned due to studies, showing that potent pharmaceutics
modulating Ab length bind rather to the protease complex. Our stud-
ies may conciliate these views.
Conclusions
This study demonstrates that NCT plays an active role in the regula-
tion of the efficiency of the sequential GSEC cleavage of APP by
establishing a direct interaction with the APP/Abn substrate. The
results of the cross-linking experiments of NCT and APPC99 validate
the position of the co-purifying helical peptide in the PDB:5FN3
GSEC structure as the substrate binding site for APP, and thus put
this co-structure as a suitable model for the investigation of the
structural–functional relationships existing within the GSEC-Abn
complexes. Our results also suggest that an extracellular interface
between GSEC and APP could be the target for GSMs (E-S stabiliz-
ers). These novel insights may conciliate different views on the loca-
tion of GSM binding pocket(s) and guide future efforts to develop
safe therapies targeting GSEC-APP/Ab assemblies, i.e., the genera-
tion of GSEC stabilizing compounds (GSSCs). Finally, this study
raises additional considerations with potential implications for the
clinic, as the remarkable involvement of NCT in the regulation of
the Ab product length suggests a potential link between single-
nucleotide variants in NCSTN and AD risk.
Materials and Methods
Antibodies and compounds
Following antibodies were used in the study: anti-FLAG M2 (F3165)
from Sigma-Aldrich, anti-PSEN-CTF (MAB5232) from Merck, anti-
human PSEN-NTF (MAB1563) from Millipore, anti-NCT (#612290)
from BD Biosciences, horseradish peroxidase (HRP)-conjugated
anti-mouse (#1721011) and anti-rabbit IgG (#1721019) from Bio-
Rad, HRP-conjugated anti-rat IgG (#P0450) from Agilent and anti-
human amyloid-beta (N) (82E1, #10323) from IBL. Anti-mouse
PSEN-NTF (B19.3), PSEN-PEN-2 (B126.2) and PSEN-APP-CTF (B63)
antibodies were made in-house. Antibodies used in the ELISA and
GSMs were obtained through collaboration with Janssen Pharma-
ceutica NV (Beerse, Belgium). The ELISA capture antibodies were
JRD/Ab37/3 for Ab37, JRF AB038 for Ab38, JRF/cAb40/28 for Ab40
and JRF/cAb42/26 for Ab42, and the detection antibody was JRF/
AbN/25 raised against the N-terminus of Ab. Acid-based GSM I (2-
[(1R,2S)-1-[4-methyl-1-[4-(trifluoromethyl)phenyl] pentyl]-2-[4-
(trifluoromethyl)phenyl]-4-piperidyl] acetic acid) and imidazole-
based GSM II (N-[2-fluoro-5-(trifluoromethyl)phenyl]-5-[3-methoxy-
4-(4-methylimidazol-1-yl) phenyl]-2-methyl-1,2,4-triazol-3-amine)
and GSM III ((3R)-3-methyl-7-(4-methyl-1H-imidazol-1-yl)-2-{[1-
methyl-5-(trifluoromethyl)-1H-indol-3-yl]methyl}-1H, 2H, 3H, 4H,
6H-pyrido [1,2-a] pyrazine-1,6-dione) were synthesized as described
previously (Crump et al, 2011; Velter et al, 2014). GSEC inhibitor X
(#565771) was purchased from Calbiochem.
Figure 7. Proposed model for GSEC-mediated cleavage of APP and its modulation by GSMs.
Once the E-S complex is formed, the first endopeptidase cut strongly destabilizes the helical transmembrane domain of APPC99, leading to the unwinding of the most C-
terminal helical part of the Ab substrate and providing the length to the “de novo” generated Ab substrate to reach the active site (model originally proposed in Szaruga et al
(2017)). The further unwinding of the Ab substrate with each sequential cleavage stretches the substrate and provides the length to fill the catalytic pockets but weakens the
GSEC-Abn interaction, until the eventual E-S dissociation triggers Ab release. Here, we propose that the extracellular interface that includes NCT (241/242), APP (K28) and the
first extracellular loop of PSEN1 anchors GSEC-APP/Abn complexes during the sequential proteolytic mechanism, and the E-S interface is the target of selected imidazole-
based GSMs.
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Generation of stable cell lines
Ncstn/ (Li et al, 2003) and Psen1/Psen2/ (Nyabi et al, 2002)
mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM)/F-12 (Life Technologies)
containing 10% fetal bovine serum (FBS) (Life Technologies).
Ncstn/ MEFs were transduced with retroviruses, carrying
pMSCVpuro plasmids encoding respective wild-type or mutant
(F239A, S240A, S240F, I241A, I241C, I241D, I241E, I241S, I241F,
I241K, I241Q, I241W, N242A, N242D, N242E, N242F, N242K,
N242W, N242Y, P243A, P234F, E244A, E244D, E244F, E244K
and E244Q) NCTs, using a replication-defective recombinant
retroviral expression system (Clontech). Human PSEN1 MEF cell
lines were generated by rescuing PSEN expression in knock-out
Psen1/Psen2/ MEFs with either wild-type human or mutant
PSEN1 (V89L, L166P, R269H) variants. Briefly, retroviruses were
generated by co-transfecting HEK293T cells with pMSCVpuro wild-
type or mutant NCT or human PSEN1-encoding plasmids and the
PIK helper plasmids, as reported previously (Cha´vez-Gutie´rrez et al,
2008). Viral particles were harvested 48 h post-transfection and
used to infect Ncstn/ or Psen1/Psen2/ fibroblasts plated at
30–40% confluency. Culture medium was supplemented with 5 lg/ml
puromycin (Sigma-Aldrich) to select clones stably expressing PSEN
or NCT, which were further maintained in DMEM/F-12, 10% FBS
and 3 lg/ml puromycin. NCT and PSEN1 expression levels and the
reconstitution of the functional GSEC complexes in the different cell
lines were analyzed by SDS–PAGE/Western blot.
Transduction of MEF cell lines with adenoviruses carrying
APP-encoding plasmids for cell-based activity assays
Mouse embryonic fibroblast cell lines were transduced with recom-
binant adenoviruses carrying plasmids encoding APPC99, as
described previously (Cha´vez-Gutie´rrez et al, 2008). Briefly, MEF
cells stably expressing either WT or mutants mNCT/hPSEN1 were
plated at the density of 1 × 105 cells/well into 12-well plates and
16 h later transduced with recombinant adenoviruses Ad5/CMV-
APP. Seven hours post-transduction, the medium was refreshed
with low-serum medium (DMEM/F-12 medium containing 0.2%
serum). The cells were then incubated for 24 h at 37°C or 42°C,
respectively, and the conditioned medium was collected for Ab anal-
ysis (Szaruga et al, 2017). When indicated, the low-serum culture
medium was supplemented with 0.3 lM or 1 lM GSMs (GSM I,
GSM II and GSM III) or vehicle control (0.1% DMSO final concentra-
tion).
MEF electroporation with plasmids encoding wild-type or
mutant APPC99-3xFLAG substrates
Mouse embryonic fibroblast cell lines were electroporated with 5 lg
pSG5**APPC99-3xFLAG-WT or pSG5**APPC99-3xFLAG-K28E plas-
mids using the NEPA21 super electroporator transfection system
(Nepagene). Freshly trypsinized cells were set to a concentration of
1.5 × 106 cells/ml in OPTI-MEM (Thermo Fisher Scientific) and
100 ll of the cell suspension was mixed with 5 lg of DNA, and
transferred to a Nepa 2 mm gap cuvette (#EC-002S, Nepagene) for
electroporation (poring pulse (voltage = 140V, length = 7.5 ms,
interval = 50 ms, # of pulses = 2, decay rate = 10% and
polarity = +); transfer pulse (voltage = 20V, length = 50 ms, inter-
val = 50 ms, # of pulses = 5, decay rate = 40% and polarity = +/)).
The electroporated cells were mixed with 400 ll DMEM/F-12
medium containing 10% FBS and 3 lg/ml puromycin immediately
after the electroporation and plated into 24-well plates. The medium
was refreshed with low-serum medium 12 h post-electroporation
and collected 36 h later for the Ab quantification.
Quantification of Ab production by (MSD) ELISA
To determine the GSEC processivity of APP, Ab37, Ab38, Ab40,
Ab42 and Ab43 levels in conditioned medium (cell-based assays)
were measured. To quantify the concentration of Ab37, Ab38, Ab40
and Ab42 peptides, Multi-Spot 96-well MSD-ELISA plates pre-coated
with anti-Ab37-, anti-Ab38-, anti-Ab40- and anti-Ab42-specific anti-
bodies using the multiplex Meso Scale Discovery (MSD) technology
were used. Non-specific protein binding to the plates was blocked
with 150 ll/well blocking buffer (PBS supplemented with 0.1%
casein) for 1.5 h at room temperature (while shaking at 600 rpm),
and the blocked plates were rinsed 5 times with 150 ll/well wash-
ing buffer (PBS supplemented with 0.05% Tween-20). 25 ll of
SULFO-TAG JRF/AbN/25 detection antibody diluted in blocking
buffer was mixed with 25 ll of standards (synthetic human Ab1-37,
Ab1-38, Ab1-40 and Ab1-42 peptides at known concentrations) or
25 ll analyzed samples, both diluted in blocking buffer, and the
mix (50 ll/well) was loaded on the plate for ELISA analysis. After
overnight incubation at 4°C, the plates were rinsed 5 times with
washing buffer and developed by the addition of 150 ll/well of the
2 × MSD Read Buffer T (Tris-based buffer containing tripropy-
lamine). The signals were read immediately on a Sector Imager
6000 (Meso Scale Discovery). To quantify the concentration of the
Ab43 peptide in cell-based assays, conditioned medium samples
were loaded on the ELISA plates pre-coated with anti-human Ab (1-
43) rabbit IgG, supplied with the human amyloid-b (1-43) (FL) assay
kit (IBL) and peptide levels were measured following the supplier’s
protocol.
Cross-linking in MEFs
Mouse embryonic fibroblast cells stably expressing either wild type
of I241C mutant mouse NCT were plated into 10 cm tissue culture
dishes at the density of 1.5 × 106 cells/dish and transduced with
recombinant adenovirus Ad5/CMV-APP bearing human APPC99, as
described above. 36 h post-transduction, the cells were collected
by scraping in ice-cold PBS and total membranes prepared. To
induce the cross-linking between free sulfhydryl groups (i.e.,
cysteines), 30 lg membrane protein resuspended in 50 mM MES
and 100 mM NaCl pH 6.5 was mixed with N-b-maleimidopropyl-
oxysuccinimide ester (BMPS, Thermo Fisher Scientific) at a final
concentration of 10 lM and incubated for 2 h on ice. The excess
of the cross-linker was removed by washing the membrane pellets
in buffer B. To promote the reaction with free amine groups,
membranes were then resuspended in 100 mM HEPES and
100 mM NaCl pH 7.5 and incubated again on ice for 2 h. Cross-
linked membranes were pelleted by ultracentrifugation, solubilized
in 4 × sample buffer (NuPAGE LDS, Thermo Fisher Scientific)
supplemented with 4% b-mercaptoethanol (BME) and analyzed by
SDS–PAGE/Western blot.
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To test for the potential formation of a disulfide bridge between
NCT-I241C and APP-K28C mutants, NCT-I241C MEF cell line was
electroporated with 7.5 lg of pSG5**APP-C99-3xFLAG-K28C plas-
mid per 1 × 106 cells. The medium was refreshed with low-serum
medium containing GSEC Inhibitor X (1 lM) 12 h post-electropora-
tion and cells were harvested 24 h later. Membrane fractions were
prepared from the electroporated cells and resuspended in 50 mM
MES and 100 mM NaCl pH 6.5. 30 lg protein (measured by Brad-
ford protein assay) was resolved by SDS–PAGE under reducing (4%
BME in sample buffer) or non-reducing (no BME in sample buffer)
conditions. The presence of the cross-linked products was evaluated
by Western blot.
Molecular dynamics simulations
The NCT-I242E mutant molecular dynamics (MD) simulation
conducted for this study was based on a 3000-ns-long simulation of
the APP-derived substrate Ab49 in complex with WT (human)
GSEC, part of a computational study of GSEC-Abn complexes
(Hitzenberger & Zacharias, 2019). The structures were based on
PDB entries 5FN2 (Bai et al, 2015a) (GSEC) and 2LP1 (Barrett et al,
2012) (APPC99). To make sure that the substrate remains in a confor-
mation that is cleavable during the sampling, a transition state-like
geometry (Singh et al, 2009) at the interface between the cleavage
(C99-V46 and C99-I47) and the active site (PSEN-D257 and PSEN-
D385) was stabilized by the use of appropriate harmonic restraints
with weak force constants (for details, cf. to the previous study;
Hitzenberger & Zacharias, 2019). The complex of GSEC-I242E and
GSEC-Ab49 was placed in a bilayer of 301 POPC molecules and
solvated in a 0.15 M KCl solution containing 53,829 water mole-
cules. Periodic boundary conditions were employed, and the rectan-
gular simulation box had a volume of approx. 2,200,000 A˚3. Lipids,
water and proteins were described by the Lipid14 (Dickson et al,
2014), the TIP3P (Mark & Nilsson, 2001) and AMBER14SB (Maier
et al, 2015) force fields, respectively. The target temperature was set
to 303.15K by the use of the Langevin thermostat (Goga et al, 2012)
with a collision frequency of 1 ps1. The desired pressure of 1.0 bar
was maintained by the Monte Carlo barostat (A˚qvist et al, 2004).
Non-bonded interactions were described up until a distance of 8 A˚,
and the particle mesh Ewald method (Darden et al, 1993) was used
to describe long-range effects. To allow for 4.0 fs time steps, the
SHAKE algorithm (Ryckaert et al, 1977) and the hydrogen mass
repartitioning method (Hopkins et al, 2015) were employed. The
simulations were performed using the CUDA (Nickolls et al, 2008)
version of PMEMD (Go¨tz et al, 2012; Le Grand et al, 2013; Salomon-
Ferrer et al, 2013), which is part of the AMBER16 simulation pack-
age (Case et al, 2016). For evaluation, a 3000-ns-long simulation
trajectory was generated. Trajectory analysis was carried out using
CPPTRAJ (Roe & Cheatham, 2013) and VMD (Humphrey et al,
1996), which was also utilized to render the simulation snapshots.
For free energy calculations, the molecular mechanics Poisson–
Boltzmann surface area (MMPBSA) (Genheden & Ryde, 2015) post-
processing method as implemented in the MMPBSA.py program
(Miller et al, 2012) has been employed. In order to account for the
effects of the POPC bilayer, an implicit lipid model with a permittiv-
ity of e = 2.0 has been used. The membrane slab was assumed to be
34 A˚ in thickness so that it covers the same region as the lipid tails
in the explicit treatment. The head group region was assumed to be
part of the aqueous layer (e = 80.0) in order to ensure a realistic
treatment of the electrostatics at the lipid–water interface where
E242 and K28 are located (this region was populated by a high
amount of water molecules—especially in the cavity region between
NCT and PSEN, which is void of lipids). The implicit lipid slab was
centered around the mean center of mass (COM) of the explicit
bilayer in the simulation. The (internal) permittivity of the protein
was assumed to be e = 1.0 and the salt concentration was set to
0.15 M. In order to estimate the influence of the I242E mutation to
DDGbind, 1,500 frames of the simulation generated for this study
were compared to the same amount of frames of the previously
performed WT GSEC-Ab49 simulation (Hitzenberger & Zacharias,
2019). Due to the large system sizes and the enormous computa-
tional effort involved in estimating changes of entropy upon bind-
ing, only PBSA-intrinsic solvation entropies have been considered.
Statistical analysis
All statistical analyses were performed using the GraphPad Prism 7
or 8 software. One-way ANOVA with Dunnett’s post hoc test was
used to test the significance of the changes between groups unless
indicated otherwise. In Fig 4, an unpaired, two-tailed Student’s
t-test was used to test the significance between tested groups. In
Fig 6, two-way ANOVA with Sidak’s post hoc test was used to
determine the response to the pharmacological treatments.
P-value < 0.05 was used as a pre-determined threshold for statistical
significance. All statistical analyses are described in the
corresponding figure legends.
Expanded View for this article is available online.
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